TGF-β not only inhibits various targets in the immune system, but also plays a role in tumor immune escape and adverse reactions to tumor immunotherapy (Batlle and Massague, 2019; Derynck et al., 2021). The gene discussed is TGFB1; the disease is neoplasm.